Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › MD › Baltimore › NPI 1598718256
Physician

Maryland Family Care, INC.

Maryland Family Care, INC. was paid $24.53M by Medicaid between Jan 2018 and Dec 2024, across 120 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 30% of everything it billed.

33Billing provider infoMARYLAND FAMILY CARE, INC.
BALTIMORE, MD 21202
33aNPI1598718256assigned 05/17/2006
28Total paid$24.53M
24GClaims498,588
24DCodes billed120
24AFirst – last monthJan 2018 – Dec 2024
Box 24A · Dates of service

Paid by month

$0$200K$400K$600K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201816,171$943K
201915,700$567K
202062,746$3.35M
202171,809$4.25M
202278,724$5.20M
2023132,377$5.65M
2024incomplete121,061$4.56M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99214 Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 30% 79,968 72,839 $7.36M
99213 Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity 27% 98,367 88,382 $6.68M
99392 Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) 6.6% 14,714 14,154 $1.63M
99391 Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) 6.4% 15,490 14,372 $1.57M
99393 Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) 3.4% 7,570 7,367 $837K
99232 Hospital visit by a doctor, follow-up daySubsequent hospital care, per day, moderate complexity 2.2% 14,713 4,819 $540K
99477 2.1% 1,676 1,430 $522K
99394 Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) 1.7% 3,433 3,356 $409K
99220 1.5% 4,346 3,886 $379K
99233 Hospital visit by a doctor, follow-up day (complex)Prolong inpt eval add15 m 1.4% 6,454 2,562 $341K
99223 Prolong inpt eval add15 m 1.2% 3,332 2,950 $290K
99238 Hospital discharge day management, 30 minutes or less 1.1% 5,512 4,898 $258K
108 more codes
99204 Doctor's office visit, new patient (more involved) 1.0% 2,221 $250K
90670 <1% 9,225 $209K
99215 Doctor's office visit, returning patient (complex) <1% 2,669 $191K
99239 Hospital discharge day management, more than 30 minutes <1% 2,009 $180K
90686 <1% 8,449 $178K
90680 <1% 7,419 $161K
99381 <1% 1,262 $134K
93000 <1% 4,982 $132K
90698 <1% 5,869 $128K
99231 Subsequent hospital care, per day, straightforward or low complexity <1% 3,339 $123K
99395 Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years <1% 892 $109K
99385 <1% 848 $108K
99308 Subsequent nursing facility care, per day, straightforward <1% 4,055 $108K
90697 <1% 4,957 $108K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward <1% 2,582 $102K
G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) <1% 4,038 $99K
90633 <1% 4,410 $97K
99203 Doctor's office visit, new patient (routine) <1% 1,231 $90K
96110 Developmental screening, with scoring and documentation, per standardized instrument <1% 8,914 $88K
90710 <1% 3,618 $80K
90677 <1% 2,701 $65K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) <1% 1,916 $64K
36415 Collection of venous blood by venipuncture <1% 15,249 $59K
90744 <1% 2,676 $58K
99226 <1% 1,069 $57K
99217 <1% 1,900 $56K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r <1% 631 $55K
99396 Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years <1% 456 $52K
G0008 Administration of influenza virus vaccine <1% 2,910 $46K
D1206 Topical application of fluoride varnish <1% 1,422 $35K
90682 <1% 1,029 $34K
96127 <1% 4,946 $29K
3074F <1% 45,250 $28K
99460 <1% 302 $26K
99225 <1% 954 $24K
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit <1% 814 $24K
99464 <1% 408 $24K
92551 <1% 2,250 $23K
99462 <1% 572 $23K
82962 <1% 1,301 $21K
90674 <1% 675 $16K
90662 <1% 1,331 $15K
90651 <1% 650 $15K
99219 <1% 322 $13K
3044F <1% 9,062 $12K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 217 $11K
90696 <1% 452 $10K
99221 <1% 100 $10K
90661 <1% 496 $9K
99386 <1% 59 $9K
0072A <1% 225 $9K
99205 Prolong outpt/office vis <1% 47 $9K
0071A <1% 202 $8K
90700 <1% 294 $7K
0001A <1% 174 $7K
G0009 Administration of pneumococcal vaccine <1% 275 $6K
99442 <1% 298 $6K
0002A <1% 157 $6K
99173 <1% 2,267 $6K
90480 <1% 138 $6K
90734 <1% 258 $5K
90648 <1% 177 $4K
99222 Initial hospital care, per day, moderate complexity <1% 211 $4K
0124A <1% 108 $4K
90715 <1% 125 $3K
99236 Prolong inpt eval add15 m <1% 15 $3K
0004A <1% 60 $2K
96161 <1% 893 $2K
90619 <1% 81 $2K
3075F <1% 1,945 $2K
99495 <1% 40 $2K
99443 <1% 64 $2K
99383 <1% 12 $2K
91318 <1% 26 $2K
0012A <1% 30 $1K
91319 <1% 13 $1K
0011A <1% 27 $1K
90688 <1% 54 $974.34
99406 <1% 80 $969.74
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 69 $962.82
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 64 $946.94
90381 <1% 16 $895.25
90707 <1% 30 $651.84
90716 <1% 30 $651.84
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 <1% 481 $607.50
90621 <1% 14 $578.88
W7000 <1% 99 $539.86
0081A <1% 17 $486.20
80305 <1% 98 $424.83
G2012 Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion <1% 40 $413.41
99309 Subsequent nursing facility care, per day, low to moderate complexity <1% 23 $381.38
90685 <1% 19 $349.20
90694 <1% 294 $320.69
99306 Prolong nursin fac eval 15m <1% 14 $320.49
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 12 $178.96
90732 <1% 45 $146.54
90653 <1% 68 $120.22
36416 <1% 596 $110.80
91308 <1% 170 $0.02
91312 <1% 80 $0.01
3078F 0% 37,617 $0.00
91300 0% 109 $0.00
3079F 0% 9,459 $0.00
91307 0% 79 $0.00
J1030 Injection, methylprednisolone acetate, 40 mg 0% 25 $0.00
85025 Blood count; complete (CBC), automated, and automated differential WBC count 0% 14 $0.00
J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg 0% 12 $0.00
83036 Hemoglobin; glycosylated (A1C) 0% 14 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialROWE, WILMA (DIRECTOR)